Alantra advises Lazeo on the sale of a minority stake to Blackstone
SECTORHealthcare
ServiceM&A
Paris – Alantra has advised the shareholders of Lazeo, a French fast-growing network of centers providing aesthetic medicine services, on the sale of a minority stake to Blackstone, a leading investment firm.
Headquartered in Paris, Lazeo is a founder-led, family-owned provider of non-invasive aesthetic medical services including laser hair removal, injectables, body contouring, and medical-grade facials. Founded in 2010 by Dr. Bernard and Dimitri Sillam with a single location in Paris, Lazeo has grown to become the number one provider in France. With 135 locations – including five in Belgium and expansion into Germany in 2023 with the acquisition of Munich-based Cleanskin – Lazeo has a significant runway for further expansion in both existing and new markets.
Founded in 1985, Blackstone is one of the world’s leading investment firms with $975 billion assets under management. Blackstone is one of the most active healthcare investors globally, investing over $27 billion in pharma, med-tech, distribution, and services. Blackstone relies on a track record of partnerships with management teams and entrepreneurs (Versace, Spanx, Superbet, etc.) and investments in the consumer and beauty sectors (ZO Skin Health, Supergoop, etc.). With this acquisition, Blackstone plans to create the European leader in the high growth aesthetic medicine market.
Dimitri Sillam, Co-Founder and CEO at Lazeo, commented: “We are thrilled and honoured to partner with Blackstone for the next phase of our growth journey. Blackstone shares our vision to make Lazeo a European champion in aesthetic medicine, and we look forward to working together to build on our significant success to date.”
Fabrice Scheer, Managing Partner at Alantra, said: “We are delighted to have supported Lazeo, the number one provider of aesthetic medicine in France, in their research for a financial partner. Their fast-growing profile is unique and attracted numerous investors. We believe Blackstone, with their experience in family-founded companies, is the best partner for Lazeo’s next growth phase.”
Related Transactions
-
Oct 2024Sell-side advisoryOct 2024SECTOR HealthcareService M&A
-
Oct 2024Sell-side advisoryOct 2024SECTOR Consumer Goods & Retail; HealthcareService M&A
-
Oct 2024Sell-side advisoryOct 2024SECTOR Consumer Goods & Retail; HealthcareService M&A
-
Aug 2024Sell-side AdvisoryAug 2024SECTOR HealthcareService M&A